Drug General Information
Drug ID
D0U0KR
Former ID
DCL001171
Drug Name
CF102
Drug Type
Small molecular drug
Indication Hepatocellular carcinoma; Hepatitis C virus infection [ICD9: 001-139, 070.4, 070.5, 070.70, 155, 573.3; ICD10:A00-B99, B17.1, B18.2, C22.0, K75.9] Phase 1/2 [550529]
Company
Can-Fite BioPharm
Structure
Download
2D MOL

3D MOL

Formula
C18H18ClIN6O4
Canonical SMILES
CNC(=O)C1C(C(C(O1)N2C=NC3=C2N=C(N=C3NCC4=CC(=CC=C4)I)Cl<br />)O)O
InChI
1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1
InChIKey
IPSYPUKKXMNCNQ-PFHKOEEOSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Agonist [550529]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 5505292011 Pipeline of Can-Fite BioPharm.
Ref 5505292011 Pipeline of Can-Fite BioPharm.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.